These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25653529)

  • 21. A Psychometric Evaluation of the German Version of the Quick Inventory of Depressive Symptomatology (QIDS-SR16) in Outpatients with Depression.
    Roniger A; Späth C; Schweiger U; Klein JP
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):e17-22. PubMed ID: 26714254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder?
    Novick D; Montgomery WS; Aguado J; Peng X; Brugnoli R; Haro JM
    Asia Pac Psychiatry; 2015 Dec; 7(4):427-35. PubMed ID: 26047023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes.
    Jain N; Carmody T; Minhajuddin AT; Toups M; Trivedi MH; Rush AJ; Hedayati SS
    Am J Nephrol; 2016; 44(3):234-44. PubMed ID: 27592294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
    Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
    Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
    Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies.
    Barros BR; Schacht A; Happich M; Televantou F; Berggren L; Walker DJ; Dueñas HJ
    Prim Care Companion CNS Disord; 2014; 16(5):. PubMed ID: 25667808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of the 16-item Quick Inventory of Depressive Symptomatology: a systematic review and meta-analysis.
    Reilly TJ; MacGillivray SA; Reid IC; Cameron IM
    J Psychiatr Res; 2015 Jan; 60():132-40. PubMed ID: 25300442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric validation of the 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR16) in military veterans with PTSD.
    Surís A; Holder N; Holliday R; Clem M
    J Affect Disord; 2016 Sep; 202():16-22. PubMed ID: 27253212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining remission from depression on two self-report symptom scales: a comparison of the Quick Inventory of Depressive Symptomatology and the Clinically Useful Depression Outcome Scale.
    Zimmerman M; Martinez J; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M
    Compr Psychiatry; 2012 Oct; 53(7):1034-8. PubMed ID: 22520091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?
    Novick D; Montgomery W; Aguado J; Kadziola Z; Peng X; Brugnoli R; Haro JM
    J Affect Disord; 2013 Jul; 149(1-3):182-8. PubMed ID: 23521872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The remission from depression questionnaire as an outcome measure in the treatment of depression.
    Zimmerman M; Martinez JH; Attiullah N; Friedman M; Toba C; Boerescu DA
    Depress Anxiety; 2014 Jun; 31(6):533-8. PubMed ID: 24115164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
    Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
    Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
    Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.
    Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
    Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. rTMS effects in patients with co-morbid somatic pain and depressive mood disorders.
    Phillips AL; Burr RL; Dunner DL
    J Affect Disord; 2018 Dec; 241():411-416. PubMed ID: 30145511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity.
    Gao K; Wang Z; Chen J; Kemp DE; Chan PK; Conroy CM; Serrano MB; Ganocy SJ; Calabrese JR
    J Affect Disord; 2013 Jun; 148(2-3):256-64. PubMed ID: 23273550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.